Location: Palo Alto, CA
CIK: 0001674712 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 8, 2023
Total Value: $913M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Genetron Holdings Ltd | 8,124,174 | $105M | 11.5% | $9.86 | — | ADS | 37186H100 |
| SLNO | Soleno Therapeutics Inc | 3,203,093 | $94.52M | 10.4% | $6.05 | 0.0% | Common | 834203309 |
| HRMY | Harmony Biosciences Holdings Inc | 2,606,247 | $85.41M | 9.4% | $36.16 | -4.0% | Common | 413197104 |
| — | Verona Pharma PLC | 4,249,918 | $69.27M | 7.6% | $6.97 | — | ADS | 925050106 |
| — | Avadel Pharmaceuticals PLC | 4,096,428 | $42.19M | 4.6% | $8.54 | — | ADR | 05337M104 |
| TARS | Tarsus Pharmaceuticals Inc | 2,262,200 | $40.2M | 4.4% | $28.48 | -37.9% | Common | 87650L103 |
| SVA | Sinovac Biotech Ltd. | 5,900,000 | $38.17M | 4.2% | $6.47 | 0.0% | SHS | P8696W104 |
| GERN | Geron Corp | 16,524,634 | $35.03M | 3.8% | $1.35 | +100.9% | Common | 374163103 |
| TERN | Terns Pharmaceuticals Inc | 6,657,992 | $33.49M | 3.7% | $11.36 | -44.2% | Common | 880881107 |
| — | Gracell Biotechnologies Inc | 10,881,144 | $31.34M | 3.4% | $4.15 | — | SPONSORED ADS | 38406L103 |
| VRDN | Viridian Therapeutics Inc | 1,678,207 | $25.74M | 2.8% | $15.47 | +23.3% | Common | 92790C104 |
| OLMA | Olema Pharmaceuticals Inc | 1,873,704 | $23.14M | 2.5% | $31.43 | -67.6% | Common | 68062P106 |
| COGT | Cogent Biosciences Inc | 2,244,941 | $21.89M | 2.4% | $8.55 | +38.8% | Common | 19240Q201 |
| ALXO | ALX Oncology Holdings Inc | 4,220,048 | $20.26M | 2.2% | $39.31 | -86.2% | Common | 00166B105 |
| ACLX | Arcellx Inc. | 503,565 | $18.07M | 2.0% | $33.15 | +4.0% | Common | 03940C100 |
| VTYX | Ventyx Biosciences Inc | 422,075 | $14.66M | 1.6% | $18.57 | +86.2% | Common | 92332V107 |
| — | Rayzebio Inc | 633,576 | $14.07M | 1.5% | $22.20 | — | Common | 75525N107 |
| — | Icosavax, Inc. | 1,704,568 | $13.21M | 1.4% | $9.93 | — | Common | 45114M109 |
| — | Astria Therapeutics Inc | 1,681,199 | $12.54M | 1.4% | $11.41 | — | Common | 04635X102 |
| VSTM | Verastem Inc | 1,538,461 | $12.51M | 1.4% | $6.94 | +38.4% | Common | 92337C203 |
| CMPS | Compass Pathway PLC | 1,608,000 | $11.9M | 1.3% | $7.40 | — | SPONSORED ADS | 20451W101 |
| ZLAB | Zai Lab Ltd ADR | 454,606 | $11.05M | 1.2% | $49.56 | — | ADR | 98887Q104 |
| — | Alpine Immune Sciences Inc | 914,913 | $10.48M | 1.1% | $10.28 | — | Common | 02083G100 |
| CRNX | Crinetics Pharmaceuticals Inc | 350,000 | $10.41M | 1.1% | $20.61 | 0.0% | Common | 22663K107 |
| DYN | Dyne Therapeutics Inc | 1,035,136 | $9.275M | 1.0% | $16.36 | -34.1% | Common | 26818M108 |
| IOBT | IO Biotech Inc | 6,173,439 | $8.705M | 1.0% | $5.62 | -68.7% | Common | 449778109 |
| APGE | Apogee Therapeutics Inc | 400,000 | $8.52M | 0.9% | $22.03 | 0.0% | Common | 03770N101 |
| KALV | KalVista Pharmaceuticals Inc. | 856,008 | $8.243M | 0.9% | $15.45 | -33.9% | Common | 483497103 |
| DCTH | Delcath Systems, Inc. | 1,855,191 | $7.514M | 0.8% | $5.69 | -17.6% | Common | 24661P807 |
| SVRA | Savara Inc | 1,913,349 | $7.232M | 0.8% | $3.56 | 0.0% | Common | 805111101 |
| CMPX | Compass Therapeutics Inc | 3,556,023 | $7.005M | 0.8% | $3.60 | -31.2% | Common | 20454B104 |
| — | Allakos Inc | 2,988,000 | $6.783M | 0.7% | $6.12 | — | Common | 01671P100 |
| WHWK | Aadi Bioscience Inc | 509,572 | $6.456M | 0.7% | $30.48 | -80.9% | Common | 00032Q104 |
| ACRS | Aclaris Therapeutics, Inc. | 898,631 | $6.156M | 0.7% | $1.36 | +527.7% | Common | 00461U105 |
| — | Instil Bio Inc | 12,486,787 | $5.344M | 0.6% | $25.08 | — | Common | 45783C101 |
| ORIC | Oric Pharmaceuticals Inc | 777,944 | $4.707M | 0.5% | $8.19 | 0.0% | Common | 68622P109 |
| — | Bolt Therapeutics Inc | 3,871,291 | $4.026M | 0.4% | $32.91 | — | Common | 097702104 |
| ARWR | Arrowhead Pharmaceuticals Inc | 137,411 | $3.692M | 0.4% | $40.33 | -24.0% | Common | 04280A100 |
| — | DBV Technologies SA | 2,708,875 | $3.684M | 0.4% | $1.77 | — | Sponsored ADR | 23306J101 |
| SERA | Sera Prognostics Inc | 1,856,011 | $3.452M | 0.4% | $10.38 | -77.0% | Common | 81749D107 |
| — | Unicycive Therapeutics | 3,470,152 | $2.984M | 0.3% | $0.86 | — | Common | 90466Y103 |
| IOVA | Iovance Biotherapeutics Inc | 655,057 | $2.981M | 0.3% | $18.48 | -64.7% | Common | 462260100 |
| — | Aligos Therapeutics Inc | 3,547,030 | $2.65M | 0.3% | $27.65 | — | Common | 01626L105 |
| FULC | Fulcrum Therapeutics Inc | 520,000 | $2.309M | 0.3% | $8.96 | -51.2% | Common | 359616109 |
| — | Clene Inc | 2,645,338 | $1.397M | 0.2% | $0.82 | — | Common | 185634102 |
| — | Impel NeuroPharma Inc | 2,884,789 | $1.24M | 0.1% | $8.85 | — | Common | 45258K109 |
| — | Aslan Pharmaceuticals Ltd | 568,182 | $1.068M | 0.1% | $3.35 | — | ADS | 04522R101 |
| BCAB | BioAtla Inc | 534,181 | $908K | 0.1% | $8.30 | -69.3% | Common | 09077B104 |
| CDXS | Codexis, Inc | 388,144 | $734K | 0.1% | $13.98 | -83.3% | Common | 192005106 |
| RZLT | Rezolute Inc | 484,439 | $639K | 0.1% | $3.32 | -51.0% | Common | 76200L309 |
| — | Amyris, Inc | 7,750,828 | $465K | 0.1% | $3.12 | — | Common | 03236M200 |
| — | Homology Medicines, Inc. | 370,068 | $433K | 0.0% | $15.54 | — | Common | 438083107 |
| — | Precision Biosciences Inc | 140,255 | $47,869 | 0.0% | $6.03 | — | Common | 74019P108 |